Stock plummeted 30% due to Q2 earnings significantly below expectations ($0.07 vs $0.57 estimate), revenue miss of $12 million, $29 million goodwill impairment charge on Hiya business, and revised full-year guidance from $20-27 million profit to $11 million loss. Weak performance across Hiya and Rise segments indicates persistent headwinds.
Articles that tag USNA but are mainly about other companies.
Reported 2025 net sales of $925 million exceeding guidance, with positive 2026 guidance of $925 million to $1.0 billion. Rise Wellness subsidiary expected to reach breakeven margins while continuing strategic growth investments.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology
